Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Sterix presents first dual aromatase and steroid sulfatase inhibitor

June 25, 2003

New antiestrogenic agents in early development at Schering AG

June 25, 2003

ES-285 enters clinical development

June 25, 2003

XL-784 enters first-in-man safety study

June 25, 2003

Potential of EB-1089 in the treatment of B-CLL

June 23, 2003

Phase II IND cleared for oral phenoxodiol

June 20, 2003

New ERbeta agonists for use in prostate cancer covered by Lilly patent

June 20, 2003

Iconix presents Rho C inhibitors with utility in cancer therapy

June 20, 2003

New nonestrogenic inhibitors of human steroid sulfatase synthesized at Theramex

June 19, 2003

Metvix label extension recommended in Australia

June 19, 2003

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...